findmyKOL
Clinical trialNCT05987241RecruitingPhase 2/PHASE3Interventional

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

SponsorNational Cancer Institute (NCI)Enrollment992Muscle Invasive Bladder Urothelial CarcinomaMuscle Invasive Renal Pelvis Urothelial CarcinomaMuscle Invasive Ureter Urothelial CarcinomaMuscle Invasive Urethral Urothelial CarcinomaStage II Bladder Urothelial Carcinoma AJCC v6 and v7Stage III Bladder Urothelial Carcinoma AJCC v6 and v7+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

499 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Arthur J E Child Comprehensive Cancer Centre

    Calgary, Alberta, Canada

    Nimira S. Alimohamed
    Recruiting
  • Cross Cancer Institute

    Edmonton, Alberta, Canada

    Scott A. North
    Recruiting
  • Bcca-Vancouver Cancer Centre

    Vancouver, British Columbia, Canada

    Bernie (Bernhard) J. Eigl
    Recruiting
  • Waterloo Regional Health Network

    Kitchener, Ontario, Canada

    Anupam Batra
    Recruiting
  • London Regional Cancer Program

    London, Ontario, Canada

    Melissa Huynh
    Recruiting
  • Ottawa Hospital and Cancer Center-General Campus

    Ottawa, Ontario, Canada

    Ana-Alicia Beltran-Bless
    Recruiting
  • Odette Cancer Centre- Sunnybrook Health Sciences Centre

    Toronto, Ontario, Canada

    Susanna Y. Cheng
    Recruiting
  • University Health Network-Princess Margaret Hospital

    Toronto, Ontario, Canada

    Srikala S. Sridhar
    Recruiting
United States
  • Cancer Center at Saint Joseph'S

    Phoenix, Arizona, United States

    Shahzad Siddique
    Recruiting
  • Mayo Clinic Hospital in Arizona

    Phoenix, Arizona, United States

    Arnab Basu
    Recruiting
  • Banner University Medical Center - Tucson

    Tucson, Arizona, United States

    Edward P. Gelmann
    Recruiting
  • University of Arizona Cancer Center-North Campus

    Tucson, Arizona, United States

    Edward P. Gelmann
    Recruiting
  • University of Arizona Cancer Center-Orange Grove Campus

    Tucson, Arizona, United States

    Suspended
  • Highlands Oncology Group - Fayetteville

    Fayetteville, Arkansas, United States

    Joseph T. Beck
    Recruiting
  • Highlands Oncology Group - Rogers

    Rogers, Arkansas, United States

    Joseph T. Beck
    Recruiting
  • Highlands Oncology Group

    Springdale, Arkansas, United States

    Joseph T. Beck
    Recruiting
  • Kaiser Permanente-Anaheim

    Anaheim, California, United States

    Helen H. Moon
    Recruiting
  • Kaiser Permanente-Baldwin Park

    Baldwin Park, California, United States

    Helen H. Moon
    Recruiting
  • Kaiser Permanente-Bellflower

    Bellflower, California, United States

    Helen H. Moon
    Recruiting
  • Kaiser Permanente Dublin

    Dublin, California, United States

    Andrea L. Harzstark
    Recruiting
  • Kaiser Permanente-Fontana

    Fontana, California, United States

    Helen H. Moon
    Recruiting
  • Kaiser Permanente-Fremont

    Fremont, California, United States

    Andrea L. Harzstark
    Recruiting
  • Kaiser Permanente Fresno Orchard Plaza

    Fresno, California, United States

    Andrea L. Harzstark
    Recruiting
  • Kaiser Permanente-Fresno

    Fresno, California, United States

    Andrea L. Harzstark
    Recruiting
  • Kaiser Permanente South Bay

    Harbor City, California, United States

    Helen H. Moon
    Recruiting
  • Kaiser Permanente-Irvine

    Irvine, California, United States

    Helen H. Moon
    Recruiting
  • Uc San Diego Moores Cancer Center

    La Jolla, California, United States

    Tyler Stewart
    Recruiting
  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California, United States

    Helen H. Moon
    Recruiting
  • Kaiser Permanente West Los Angeles

    Los Angeles, California, United States

    Helen H. Moon
    Recruiting
  • Keck Medicine of Usc Koreatown

    Los Angeles, California, United States

    Active, not recruiting
  • Los Angeles General Medical Center

    Los Angeles, California, United States

    Active, not recruiting
  • Ucla / Jonsson Comprehensive Cancer Center

    Los Angeles, California, United States

    Alexandra Drakaki
    Recruiting
  • Usc / Norris Comprehensive Cancer Center

    Los Angeles, California, United States

    Active, not recruiting
  • Kaiser Permanente- Modesto Mob Ii

    Modesto, California, United States

    Andrea L. Harzstark
    Recruiting
  • Kaiser Permanente-Modesto

    Modesto, California, United States

    Andrea L. Harzstark
    Recruiting
  • Usc Norris Oncology/hematology-Newport Beach

    Newport Beach, California, United States

    Active, not recruiting
  • Kaiser Permanente-Oakland

    Oakland, California, United States

    Andrea L. Harzstark
    Recruiting
  • Kaiser Permanente-Ontario

    Ontario, California, United States

    Helen H. Moon
    Recruiting
  • Stanford Cancer Institute Palo Alto

    Palo Alto, California, United States

    Ali R. Khaki
    Recruiting
  • Kaiser Permanente - Panorama City

    Panorama City, California, United States

    Helen H. Moon
    Recruiting
459 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

NivolumabRelatlimab
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Feb 2024
Primary completion
2 Sept 2030
Completion
2 Sept 2030
Last update posted
7 Jul 2026
Registered enrollment
992
Registry id
NCT05987241

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.